| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Med and Dev Officer | Chief Development Officer
1 company
Pizzuti Dana is a Chief Med and Dev Officer at CRNX. Recent filings cover 0 purchases and 21 sales. Those positions are worth an estimated $1.1M at current prices.
Our model assigns Pizzuti Dana a middling insider score of 56/100, based on 17 past trades. Over a 12-month horizon, 54.5% of those trades were profitable, with an average 12-month return of -7.1%.
Pizzuti Dana's largest disclosed position is in CRNX as Chief Med and Dev Officer, worth about $1.1M. The recent filings there lean toward selling, a net 178,891 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sale+OE10b5-1 | 5,000 | $45.02 | $225,100.00 | -7.0% | -10.0% | - | |
| Nov 3, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sale+OE10b5-1 | 5,000 | $42.66 | $213,312.00 | -7.0% | +15.2% | - | |
| Oct 1, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sale+OE10b5-1 | 5,000 | $41.81 | $209,050.00 | -7.0% | +13.9% | - | |
| Sep 2, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sale+OE10b5-1 | 5,000 | $32.10 | $160,500.00 | -4.9% | +35.9% | +155.1% | |
| Aug 22, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sale+OE10b5-1 | 30,000 | $30.43 | $912,900.00 | -31.2% | +35.7% | +173.9% | |
| Aug 20, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sell10b5-1 | 6,492 | $29.18 | $189,436.56 | -8.9% | +47.9% | +191.1% | |
| Mar 19, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sell10b5-1 | 2,515 | $34.20 | $86,021.37 | -3.4% | -11.0% | +3.3% | |
| Feb 3, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sale+OE10b5-1 | 5,000 | $39.07 | $195,350.00 | -13.6% | -13.3% | +28.8% | |
| Jan 3, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sale+OE10b5-1 | 15,000 | $52.09 | $781,350.00 | -33.9% | -45.7% | -12.1% | |
| Oct 3, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sale+OE10b5-1 | 14,375 | $54.63 | $785,306.25 | -33.5% | -2.3% | -22.6% |